wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33373033-AFC2B77A-D65A-451B-9053-745DAE89AD2F
Q33373033-AFC2B77A-D65A-451B-9053-745DAE89AD2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373033-AFC2B77A-D65A-451B-9053-745DAE89AD2F
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
P2860
Q33373033-AFC2B77A-D65A-451B-9053-745DAE89AD2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373033-AFC2B77A-D65A-451B-9053-745DAE89AD2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1462ee53b0a0d49ebcbf69225dddf34c5584158c
P2860
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.